Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder

The aim of this study was to compare the efficacy and tolerability of reboxetine, a uniquely selective noradrenaline reuptake inhibitor, with the selective serotonin reuptake inhibitor, fluoxetine. A double-blind, randomized, parallel-group, multicentre design was employed. One hundred and sixty-eig...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International clinical psychopharmacology 1999-03, Vol.14 (2), p.73-80
Hauptverfasser:	Massana, J, Möllerb, H-J, Burrows, G D, Montenegro, R M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antidepressive Agents - therapeutic use Biological and medical sciences Depressive Disorder - drug therapy Double-Blind Method Female Fluoxetine - therapeutic use Humans Male Medical sciences Middle Aged Morpholines - adverse effects Morpholines - therapeutic use Neuropharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!